These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 2998991

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Epstein-Barr virus and Burkitt's lymphoma worldwide: the causal relationship revisited.
    de-Thé G.
    IARC Sci Publ; 1985; (60):165-76. PubMed ID: 2998987
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Endemic Burkitt's lymphoma as a polymicrobial disease: new insights on the interaction between Plasmodium falciparum and Epstein-Barr virus.
    Chene A, Donati D, Orem J, Mbidde ER, Kironde F, Wahlgren M, Bejarano MT.
    Semin Cancer Biol; 2009 Dec; 19(6):411-20. PubMed ID: 19897039
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Squamous-cell carcinoma, Kaposi's sarcoma and Burkitt's lymphoma are consequences of impaired immune surveillance of ubiquitous viruses in acquired immune deficiency syndrome, allograft recipients and tropical African patients.
    Purtilo DT, Manolov G, Manolova Y, Harada S, Lipscomb H.
    IARC Sci Publ; 1984 Dec; (63):749-70. PubMed ID: 6100288
    [Abstract] [Full Text] [Related]

  • 8. Lymphotropic viruses, Epstein-Barr virus (EBV) and human T-cell lymphotropic virus-I (HTLV-I)/adult T-cell leukemia virus (ATLV), and HTLV-III/human immune deficiency virus (HIV) as etiological agents of malignant lymphoma and immune deficiency.
    Purtilo DT.
    AIDS Res; 1986 Dec; 2 Suppl 1():S1-6. PubMed ID: 2881552
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. A potential role for antigen selection in the clonal evolution of Burkitt's lymphoma.
    Jain R, Roncella S, Hashimoto S, Carbone A, Francia di Celle P, Foa R, Ferrarini M, Chiorazzi N.
    J Immunol; 1994 Jul 01; 153(1):45-52. PubMed ID: 8207254
    [Abstract] [Full Text] [Related]

  • 13. Epstein-Barr virus-associated lymphoproliferative disorders.
    Purtilo DT, Strobach RS, Okano M, Davis JR.
    Lab Invest; 1992 Jul 01; 67(1):5-23. PubMed ID: 1320711
    [Abstract] [Full Text] [Related]

  • 14. The LCR of EBV makes Burkitt's lymphoma endemic.
    Niller HH, Salamon D, Banati F, Schwarzmann F, Wolf H, Minarovits J.
    Trends Microbiol; 2004 Nov 01; 12(11):495-9. PubMed ID: 15488390
    [Abstract] [Full Text] [Related]

  • 15. The in vivo binding site for oncoprotein c-Myc in the promoter for Epstein-Barr virus (EBV) encoding RNA (EBER) 1 suggests a specific role for EBV in lymphomagenesis.
    Niller HH, Salamon D, Ilg K, Koroknai A, Banati F, Bauml G, Rucker O, Schwarzmann F, Wolf H, Minarovits J.
    Med Sci Monit; 2003 Jan 01; 9(1):HY1-9. PubMed ID: 12552250
    [Abstract] [Full Text] [Related]

  • 16. Virus-associated lymphomas, leukaemias and immunodeficiencies in Africa.
    de-Thé G.
    IARC Sci Publ; 1984 Jan 01; (63):727-44. PubMed ID: 6100286
    [Abstract] [Full Text] [Related]

  • 17. Epstein-Barr virus-associated Burkitt's lymphoma in India.
    Venkitaraman AR, John TJ, Rangad F, Singh AD, Date A, Lenoir G.
    Trop Geogr Med; 1983 Sep 01; 35(3):273-7. PubMed ID: 6316592
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Epidemiology of Burkitt's lymphoma: other risk factors.
    Evans AS.
    IARC Sci Publ; 1985 Sep 01; (60):197-204. PubMed ID: 2998989
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.